A groundbreaking work by Fridlender and colleagues [16] had illustrated that TGF-β in tumor microenvironment can generate a functional transition from the proinflammatory neutrophil phenotype (termed “N1”) to the anti-inflammatory phenotype (termed “N2”); [74]. This evidence concerns the gene TGFB1 and neoplasm.